Characteristics of 829 non-small-cell lung cancer patients by family history of lung cancer.

<p>Characteristics of 829 non-small-cell lung cancer patients by family history of lung cancer.</p

Impact of <i>EGFR</i> activating mutation on survival of non-small-cell lung cancer patients by family history of lung cancer: Multivariate analysis results.

<p>Impact of <i>EGFR</i> activating mutation on survival of non-small-cell lung cancer patients by family history of lung cancer: Multivariate analysis results.</p

Summary of studies of the association between family history and <i>EGFR</i> activating mutations or survival in lung cancer patients.

<p>Summary of studies of the association between family history and <i>EGFR</i> activating mutations or survival in lung cancer patients.</p

Impact of family history of lung cancer on survival of patients with non-small-cell lung cancer.

<p>Impact of family history of lung cancer on survival of patients with non-small-cell lung cancer.</p

Clinical variables for predicting <i>EGFR</i> activating mutations: Multiple logistic regression analysis results.

<p>Clinical variables for predicting <i>EGFR</i> activating mutations: Multiple logistic regression analysis results.</p

Additional file 1: Table S1. of Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients

Multivariate analyses of the factors that are predictive of overall survival in all patients apart from the new score, which use the neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion. (DOCX 16.8 kb

Baseline Characteristics of Participants (n = 185).

<p>Baseline Characteristics of Participants (n = 185).</p

Attitudes towards E-Cigarette Regulation among Participants.

<p>Attitudes towards E-Cigarette Regulation among Participants.</p

Counseling Preparedness on E-Cigarette Use among Participants.

<p>Counseling Preparedness on E-Cigarette Use among Participants.</p

Opinions on the public funding of national lung cancer screening program among lung cancer specialist physicians.

<p>Opinions on the public funding of national lung cancer screening program among lung cancer specialist physicians.</p